Anti-Tumor Necrosis Factor Treatment Does Not Decrease the Risk of Type 2 Diabetes in Patients With Inflammatory Bowel Disease.

Subjects

Subjects :

Humans
Tumor Necrosis Factor-alpha
Necrosis
Infliximab
Diabetes Mellitus, Type 2 complications
Diabetes Mellitus, Type 2 drug therapy
Inflammatory Bowel Diseases complications
Inflammatory Bowel Diseases drug therapy

Details

Language :

English

ISSN :

1542-7714

Volume :

21

Issue :

12

Database :

MEDLINE

Journal :

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Publication Type :

Academic Journal

Accession number :

36566818

Full Text :

https://doi.org/10.1016/j.cgh.2022.12.011